Skip to main content

Table 4 Performance of the global component in relation to the different control groups

From: Development and validation of a screening tool for SPondyloArthritis Screening in Sub-Saharan Africa: SpASSS questionnaire

 

Se (%)

Sp (%)

PPV (%)

NPV (%)

AUC

SpA cases vs non-SpA rheumatic controls

97.4

92.0

74.0

99.3

0.947 (0.903–0.991)

SpA cases vs healthy control population

100.0

93.9

74.0

100.0

0.982 (0.966–0.998)

SpA case vs the two control groups

97.4

96.4

74.0

99.7

0.967 (0.939–0.995)

  1. Se Sensivity, Sp Specificity, PPV Positive predictive value, NPV Negative predictive value, AUC Area under the curve